PUBLISHER: The Business Research Company | PRODUCT CODE: 1392583
PUBLISHER: The Business Research Company | PRODUCT CODE: 1392583
“Contraceptives Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for contraceptives? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The contraceptives market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Contraceptive refers to a method or act that involves the use of a variety of medicines, sexual behaviours, chemicals, medications, or surgical procedures to intentionally prevent conception. Contraceptive is any method, measure, or action designed to keep a woman from getting pregnant.
The main product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intra-uterine devices. Oral contraceptive pills are contraceptive tablets or birth control pills to prevent pregnancy. It includes hormones that prevent eggs from being released from the ovaries. The contraceptives are used by a wide range of age groups, ranging from 15-24 years, 25-34 years, 35-44 years, and over 44 years. The contraceptives are distributed by clinics, hospitals, independent pharmacies, and other locations.
The contraceptives market research report is one of a series of new reports from The Business Research Company that provides contraceptives market statistics, including contraceptives industry global market size, regional shares, competitors with a contraceptives market share, detailed contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptives industry. This contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The contraceptives market size has grown strongly in recent years. It will grow from $26. 2 billion in 2023 to $28. 25 billion in 2024 at a compound annual growth rate (CAGR) of 7. 8%. The growth in the historic period can be attributed to introduction of the birth control pill, increased awareness and education about contraception, legal and social changes promoting reproductive rights, global population control initiatives, increase in the use of generic and low-cost drugs and devices.
The contraceptives market size is expected to see strong growth in the next few years. It will grow to $38. 02 billion in 2028 at a compound annual growth rate (CAGR) of 7. 7%. The growth in the forecast period can be attributed to growing focus on male contraceptives, increased access to contraception in developing countries, integration of digital health technologies in contraception, rising demand for long-acting reversible contraceptives (larcs), growing accessibility to over-the-counter drugs on the online platform. Major trends in the forecast period include technological advancements in contraceptive methods, shift towards non-hormonal and natural contraceptive methods, expansion of over-the-counter access to certain contraceptives, emphasis on user-friendly and discreet contraceptive options, integration of telemedicine in contraceptive counseling and prescriptions.
The rising frequency of sexually transmitted illnesses or diseases is driving the demand for contraceptives. Sexually transmitted diseases (STDs) are infections spread from one person to another through sexual interaction. The most typical contact occurs during anal, oral, and vaginal intercourse and they can spread through other close physical contact methods. Contraceptives are employed to manage the transmission of sexually transmitted diseases like herpes and HPV, primarily through skin-to-skin contact. For instance, in May 2023, according to the Minnesota Department of Health, a US-based state health agency of the State of Minnesota, primary and secondary syphilis cases climbed 19% in 2022, from 564 in 2021 to 676 in 2022. In 2022, 20 instances of congenital syphilis in babies were recorded. This represents a 42 % rise from 2021 when 14 cases of congenital syphilis were documented. Therefore, the increase in sexually transmitted illnesses or diseases is expected to boost the demand for contraceptives during the forecast period.
The global rise in population rates is expected to propel the growth of the contraceptive market in the coming years. Population refers to the overall number of individuals, species, or people living in a certain geographic region, country, or the entire planet. Contraceptives play a significant part in decreasing population by allowing couples and individuals to regulate and plan their household size and child spacing. For instance, in December 2022, according to the United Nations Conference on Trade and Development, a Switzerland-based intergovernmental body inside the United Nations Secretariat that promotes developing nations' interests in global commerce, the global population is expected to have increased by 0. 9% in 2021 and to exceed 8 billion by 2022. Therefore, the global rise in population rates is driving the contraceptive market.
Technology advancement is a key trend gaining popularity in the contraceptive market. Digital Contraceptives are the latest trend in the contraceptives market. Digital Contraception is a way of tracking periods online to know which days are riskier for pregnancy. In March 2021, Clue, a Berlin-based femtech company, received FDA approval to market Clue Birth Control, all-digital contraception based on period monitoring data. The birth control function can identify when days are high or low risk for pregnancy by integrating user menstrual cycle data with Clue's prediction algorithm. Users can then adjust their habits to fit their risk tolerance. Clue recommends that users refrain from sex entirely or use another form of contraception, such as condoms, on high-risk days.
Major companies operating in the contraceptives market are focusing on innovative products, such as Opill, progestin-only daily oral contraceptives, to better meet the needs of their existing consumers. Opill progestin-only daily oral contraceptives, often known as the mini-pill, are a kind of birth control pill that includes just progestin, a synthetic version of the hormone progesterone. For instance, in July 2023, Perrigo Company plc, an Ireland-based manufacturing company of over-the-counter pharmaceuticals, announced U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill is the very first birth control pill available without a prescription in the United States. Opill can significantly improve women's availability of contraceptives and is a genuine testament to Perrigo's constant dedication to delivering meaningful solutions that improve people's lives.
In December 2021, Bayer AG, a Germany-based pharmaceutical and biotechnology company, acquired Vividion Therapeutics Inc. for an undisclosed amount. Through the acquisition, Bayer's drug development capabilities are strengthened by the innovative chemo-proteomics technology. Vividion's revolutionary strategy finds previously undiscovered binding sites in intractable targets, resulting in first-in-class new medicines in indications with significant unmet medical needs. Vividion's technology has already demonstrated pre-clinical usefulness in cancer and immune-related disorders, with the potential to extend into more therapeutic areas. Vividion will function autonomously and at arm's length. Vividion Therapeutics Inc. is a US-based biotechnology company.
Major companies operating in the in the contraceptives market report are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.
North America was the largest region in the contraceptives market in 2023 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
The contraceptive market consists of sales of combined pills, Contraceptive patch, and female condoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.